Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Peking University Cancer Hospital & Institute
Condition: Breast Cancer
NCT02878057
Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.